Industry

Expands bioanalytical services to include many emerging areas worldwide MALVERN, Pa.–(BUSINESS WIRE)–Alliance Pharma (Alliance), a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, today closed on the purchase of Drug Development Solutions (DDS), a U.K.-based bioanalytical and material science testing contract research organization (CRO), from LGC. Ampersand Capital … [Read more…]

BURLINGTON, Ontario–(BUSINESS WIRE)–$ELMT—Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the “Company” or “Element”), is pleased to announce that its latest innovation, Rejuvenate™ Immune Health, is now available to consumers on the Amazon platform in the United States through the Company’s distribution partnership with e-commerce accelerator Pattern Inc. (“Pattern”). Rejuvenate™ Immune Health is a powdered drink … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Drug Class and Distribution Channel” report has been added to ResearchAndMarkets.com’s offering. The chemotherapy-induced peripheral neuropathy market is expected to grow from US$ 813.48 million in 2021 to US$ 1,174.26 million by 2028; it is estimated to grow … [Read more…]

— Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors — — Funding will support next stage of clinical and corporate development — GHENT, Belgium–(BUSINESS WIRE)–Agomab Therapeutics NV (‘Agomab’) today announced it has extended its Series B financing round with an additional close of $40.5 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “mRNA Platform – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Beyond Covid-19, mRNA-based therapies hold promise for combatting cancer, infectious diseases such as malaria and flu, and rare genetic diseases. Results from early animal testing demonstrates the ability of mRNA-based therapeutics to provide protection against viruses such as … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “microRNA Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The global microRNA market is projected to grow with a CAGR of 15.6% during the forecast period (2022-2027). The COVID-19 pandemic affected health care systems globally and resulted in the interruption of usual care in many … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Nutrigenomics Testing Market – Growth, Trends, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Global Nutrigenomics Testing market is expected to register a 13.3% of CAGR over the forecast period. The major factors for the market growth are increasing burden of lifestyle disorders and gaining popularity of personalized … [Read more…]

  MELBOURNE, Australia & ST. GALLEN, Switzerland–(BUSINESS WIRE)–Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Limited (ASX: CSL; USOTC:CSLLY) today announced an update regarding the Vifor Pharma AG acquisition. On January 18, 2022, CSL Behring AG (the Offeror) published the offer prospectus (the Offer Prospectus) for its public tender offer according to … [Read more…]

– Introducing digital transformation (DX) for monitoring work and reducing new drug development costs – TOKYO–(BUSINESS WIRE)–Aculys Pharma, Inc. (“Aculys Pharma” Headquarters: Minato-ku, Tokyo, President and CEO: Kazunari Tsunaba), a company focused on the development and commercialization of new innovative drugs in the fields of neurology and psychiatry, has entered into a contract with SUSMED, … [Read more…]

SHORT HILLS, N.J.–(BUSINESS WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”) has been informed of preliminary topline results from the National Institute of Allergy and Infectious Diseases’ (NIAID) ACTIV-5/BET-B trial evaluating lenzilumab plus remdesivir versus placebo plus remdesivir in hospitalized COVID-19 patients. The trial did not achieve statistical significance on the primary endpoint, which was defined as the … [Read more…]